References
- Machida K, Tsuchiya-Suzuki A, Sano K, Arima K, Saito Y, Kametani F, Ikeda SI. Postmortem findings in a patient with cerebral amyloid angiopathy actively treated with corticosteroid. Amyloid 2012;19:47–52
- Maruyama K, Kametani F, Ikeda S, Ishihara T, Yanagisawa N. Characterization of amyloid fibril protein from a case of cerebral amyloid angiopathy showing immunohistochemical reactivity for both beta protein and cystatin C. Neurosci Lett 1992;144:38–42
- Castaño EM, Prelli F, Soto C, Beavis R, Matsubara E, Shoji M, Frangione B. The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type: Implications for the role of Amyloid-beta1-42 in Alzheimer’s disease. J Biol Chem 1996;271:32185–91
- Roher AE, Kokjohn TA, Esh C, Weiss N, Childress J, Kalback W, Luehrs DC, et al. The human amyloid-beta precursor protein770 mutation V717F generates peptides longer than amyloid-beta-(40-42) and flocculent amyloid aggregates. J Biol Chem 2004;279:5829–36
- Nishituji K, Tomiyama T, Ishibashi K, Kametani F, Ozawa K, Okada R, Maat-Schieman ML, et al. Cerebral vascular accumulation of Dutch-type Abeta42, but not wild-type Abeta42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type. J Neurosci Res 2007;85:2917–23